Andrew Doyle

Andrew Doyle is a Principal Associate Scientist at Prime Medicine, Inc. with extensive experience in molecular and cellular biology, particularly in the field of genetic and hematological disorders. Prior to their current role, Andrew has held positions at Constellation Pharmaceuticals, Vertex Pharmaceuticals, and various research and academic institutions such as Massachusetts General Hospital and Northeastern University. Andrew has a Master of Science in Bioengineering and Biomedical Engineering from Northeastern University and a Bachelor of Science in Biological Engineering from Louisiana State University.